abstract |
The invention relates to methods for preventing and treating hepatic fibrosis using A2B adenosine receptor antagonists, and to the utility in the treatment and prevention of liver damage caused by alcohol abuse, surgical intervention, viral hepatitis, ingestion of hepatotoxic drugs, or other liver diseases. The invention also relates to pharmaceutical compositions for use in the method. |